New Finite-Sample Certificate for Adaptive Selective Conformal Risk Control
Researchers have proposed a joint finite-sample certificate for selective conformal risk control that simultaneously bounds prediction risk, acceptance probability, and deployment utility under adaptive threshold selection. The method combines three confidence bounds—an empirical-Bernstein ratio bound, a Clopper–Pearson acceptance bound, and a two-sided utility bound—improving acceptance-floor dependence from 1/p_min to 1/√p_min over prior Hoeffding-based approaches. The work addresses a practical safety gap in deploying AI systems that abstain on uncertain inputs, offering tighter guarantees on standard vision benchmarks.
Selective predictors—AI models that answer only on inputs where they are sufficiently confident and abstain otherwise—require formal safety certificates to be deployed responsibly. Existing approaches based on Hoeffding-style range bounds can produce loose or vacuous guarantees, particularly regarding the minimum acceptance rate. The proposed certificate treats selected risk directly as a ratio, coupling three distinct confidence bounds to simultaneously certify risk, acceptance probability, and utility within a single framework valid over a finite grid of candidate thresholds. On ImageNet (tested with three ResNet architectures) and COCO val 2017 panoptic segmentation, the method opens a +22 percentage-point certified-acceptance frontier over Hoeffding-CRC and is approximately 10× tighter than a non-vacuous matched-valid baseline. The authors are careful to note these gains are regime-scoped and not universal: no improvement was observed on the ADE20K benchmark. The certifier operates in O(N_cert × m) time, making it computationally tractable. The work has been submitted to arXiv and has not yet undergone formal peer review.
What's missing
As a preprint, this work has not yet been peer-reviewed. Key open questions include: whether the regime conditions under which the certificate outperforms Hoeffding-CRC can be identified a priori without empirical tuning; and why gains are absent on ADE20K and whether dataset characteristics explain this.
What different sources said
- arXiv cs.LGCenter
A Joint Finite-Sample Certificate for Adaptive Selective Conformal Risk Control
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.